Outlook Therapeutics, Inc.

OTLK · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 17 employees
265
SEC Filings
$0.6665
Close 2026-09-04
17
Employees

Business Summary

Outlook Therapeutics is a biopharmaceutical company focused on ONS-5010/LYTENAVA, the first approved ophthalmic formulation of bevacizumab, authorized by the European Commission (EU) and MHRA (UK) for treating wet age-related macular degeneration (wet AMD) in adults. The company launched directly in Germany and the UK in June 2025 and has a BLA under FDA review for U.S. approval. ONS-5010/LYTENAVA is manufactured in the United States.

Latest Stock Quote

OTLK 2026-09-04 $0.6665 O:$0.6599 H:$0.6962 L:$0.6451 Vol:6.4M VWAP:$0.6714
origin leaf: null

Next Earnings

expected 2026-12-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-12-192025-09-300001104659-25-123264EDGAR98K words
2024-12-272024-09-300001558370-24-016491EDGAR94K words
2023-12-222023-09-300001558370-23-020000EDGAR85K words
2022-12-292022-09-300001558370-22-019036EDGAR81K words
2021-12-232021-09-300001558370-21-017007EDGAR—
2020-12-232020-09-300001558370-20-014540EDGAR—
2019-12-192019-09-300001104659-19-074095EDGAR—
2018-12-182018-09-300001144204-18-065142EDGAR—
2017-12-292017-09-300001571049-17-008779EDGAR—
2016-12-292016-09-300001571049-16-020882EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-182026-06-300001104659-26-098415EDGAR30K words
2026-02-172025-12-310001104659-26-016554EDGAR23K words
2025-08-142025-06-300001558370-25-011588EDGAR21K words
2025-05-152025-03-310001558370-25-007873EDGAR28K words
2025-02-142024-12-310001558370-25-001022EDGAR26K words
2024-08-142024-06-300001558370-24-012234EDGAR28K words
2024-05-152024-03-310001558370-24-008318EDGAR27K words
2024-02-142023-12-310001558370-24-001172EDGAR24K words
2023-08-142023-06-300001558370-23-014866EDGAR24K words
2023-05-152023-03-310001558370-23-009942EDGAR23K words
2023-02-142022-12-310001558370-23-001286EDGAR21K words
2022-08-102022-06-300001558370-22-013086EDGAR22K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-180001104659-26-108952EDGAR0K words
2026-08-270001104659-26-102446EDGAR6K words
2026-08-140001104659-26-096510EDGAR24K words
2026-08-140001104659-26-096478EDGAR4K words
2026-08-120001104659-26-094848EDGAR41K words
2026-07-240001104659-26-086406EDGAR1K words
2026-07-240001104659-26-086685EDGAR2K words
2026-07-160001104659-26-084242EDGAR1K words
2026-03-250001104659-26-034601EDGAR21K words
2026-03-160001104659-26-028103EDGAR3K words

265 total filings indexed. 233 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

wet-age-related-macular-degeneration-(wet-amd) anti-vegf-retina-therapeutics diabetic-macular-edema-(dme) branch-retinal-vein-occlusion-(brvo) ophthalmic-biologics biologics-license-application-(bla) marketing-authorization-application-(maa) special-protocol-assessment-(spa) international-recognition-procedure-(irp)

Company Identity

CIK0001649989
TickerOTLK
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.outlooktherapeutics.com
Listed2016-05-13

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 1eed442d6cc1b4cf13b8f45ad940f6b99a4bbc0509320df131153fdd223b9647
parent: 6be5de9461e8b661fc7523915b5cd5148545f1a091b6fbd1a36be3d7bbae5971
content hash: 9d5eaab1799a72b6268a47c633429f805b8d0971f42317dea2e1111d86559cab
signed: 2026-09-30T19:02:44.929Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up OTLK using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on OTLK, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/OTLK (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.